Milestone Scientific Inc. (MLSS) is a Medical - Instruments & Supplies company in the Healthcare sector, currently trading at $0.29. It has a SharesGrow Score of 56/100, indicating a above average investment profile with 3 out of 7 criteria passed.
Analyst consensus target is MLSS = $4 (+1269.9% upside).
Valuation: MLSS trades at a trailing Price-to-Earnings (P/E) of -4 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.36.
Financials: revenue is $9M, +1.1%/yr average growth. Net income is $6M (loss), growing at +10.3%/yr. Net profit margin is -63.8% (negative). Gross margin is 71.4% (+15.7 pp trend).
Balance sheet: total debt is $1M against $3M equity (Debt-to-Equity (D/E) ratio 0.36, conservative). Current ratio is 1.81 (strong liquidity). Debt-to-assets is 13.1%. Total assets: $8M.
Analyst outlook: 1 / 1 analysts rate MLSS as buy (100%) — strong consensus.
SharesGrow 7-Criteria breakdown: Value 100/100 (Pass), Growth 63/100 (Pass), Past 0/100 (Fail), Health 67/100 (Partial), Moat 50/100 (Partial), Future 100/100 (Pass), Income 10/100 (Fail).
